Dr. Anna Gebhardt

Dr. Anna Gebhardt studied chemistry and biochemistry at the Ludwig-Maximilians-Universität in Munich, Germany and received her PhD in biochemistry with work on the innate immune system during viral infections at the Max Planck Institute. She joined Coriolis in 2018 as a Scientist and Project Manager. Today, Anna Gebhardt is Business Development Manager at Coriolis with a focus on gene and cell therapy drug products/ATMPs.